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Available online 18 January 2007Chronic cerebral hypoperfusion has been associated with cognitive decline in aging and
Alzheimer's disease. Moreover, the pattern of cerebral blood flow in mild cognitive
impairment has emerged as a predictive marker for the progression into Alzheimer's
disease. The reconstruction of a pathological condition in animal models is a suitable
approach to the unraveling of causal relationships. For this reason, permanent, bilateral
occlusion of the common carotid arteries (2VO) in rats has been established as a procedure
to investigate the effects of chronic cerebral hypoperfusion on cognitive dysfunction and
neurodegenerative processes. Over the years, the 2VO model has generated a large amount
of data, revealing the 2VO-related pattern of cerebral hypoperfusion andmetabolic changes,
learning andmemory disturbances, failure of neuronal signaling, and the neuropathological
changes in the hippocampus. In addition, the model has been introduced in research into
ischemic white matter injury and ischemic eye disease. The present survey sets out to
provide a comprehensive summary of the achievements made with the 2VO model, and a
critical evaluation and integration of the various results, and to relate the experimental data
to human diseases. The data that have accumulated from use of the 2VO model in the rat
permit an understanding of the causative role played by cerebral hypoperfusion in
neurodegenerative diseases. Thorough characterization of the model suggests that 2VO in
the rat is suitable for the development of potentially neuroprotective strategies in
neurodegenerative diseases.
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Disorders of the cerebral circulation are the causes of or
factors contributing to numerous neurological and psychiatric
illnesses. A sudden disruption of the blood supply to distinct
brain regions leads to stroke, while a moderate but persistent
reduction in regional cerebral blood flow (CBF) compromises
memory processes and contributes to the development and
progression of dementia. The association of decreased CBF,
particularly in the temporal and parietal cortices, with
Alzheimer's disease (AD) has been firmly established (de la
Torre, 2002; Farkas and Luiten, 2001; Matsuda, 2001). Addi-
tionally, the degree or pattern of cerebral hypoperfusion in
mild cognitive impairment has been suggested as a predictive
marker for the progression to AD (Borroni et al., 2006; Hirao et
al., 2005). Furthermore, global cerebral hypoperfusion can
occur in patients who have suffered a cardiac arrest or those
who undergo complex cardiac surgery, and this condition can
lead to a poor neurologic outcome (Hypothermia after Cardiac
Arrest Study Group, 2002; Nussmeier, 2002). For an under-
standing of the role of the cerebrovascular pathology in the
development of a cognitive dysfunction and dementia, it is
important to explore the cerebral hypoperfusion-related
metabolic changes, the distinct neurodegenerative and cog-
nitive correlates of hypoperfusion, and the causal relation-ships between these factors. Furthermore, recognition of
particular mechanisms in the chain of events from chronic
cerebral hypoperfusion to a cognitive decline may identify
potential targets for effective therapies. For these purposes, a
number of animal models have been introduced.
Vessel occlusion studies aim at creating ischemic or
oligemic injuries with various degrees of severity in the brains
of experimental animals. The rat is a frequently used species
in consequence of the good survival rate, the satisfactory
recovery from surgery, the easy and reproducible behavioral
testing, the relatively low costs, and ethical acceptance. A
great variety of rat vessel occlusion models have emerged,
most of which are applied in stroke research. Since stroke is an
acute pathophysiological condition, the experimental stroke
models are generally employed to investigate the short-term
effects of vessel occlusion, and the possibilities of rapid
interventions designed to limit neurodegenerative processes.
To this end, two experimental approaches have evolved in the
rat: transient occlusion of the middle cerebral artery and
permanent occlusion of extracranial vessels (e.g. vertebral and
carotid arteries) in combination with experimental hypoten-
sion or hypoxia. In the frequently used transient ischemia
models, there is an obvious component of reperfusion, the
brain damage is focal and severe, the ischemic site can
typically be divided into a core and a penumbra region,
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of the brain damage, and even seizures may develop.
For the reproduction of chronic cerebral hypoperfusion as it
occurs in human aging and AD, permanent, bilateral occlusion
of the common carotid arteries of rats (2-vessel occlusion,
2VO) has been introduced. The rat is a suitable rodent species
for this purpose because the complete circle of Willis affords
incessant (but reduced) blood flow after the onset of 2VO. In
contrast, the lack or the underdevelopment of the posterior
communicating arteries of the circle of Willis causes severe
ischemia during 2VO in gerbils andmost of the mouse strains.
In the rat 2VO model, the surgical methods, the permanent
nature of the ligation of the common carotid arteries, the lack
of exacerbating factors (hypotension or hypoxia), and the
experimental animal species (the rat) are standard, and
therefore the 2VO model can be regarded as a single defined
entity from a technical point of view. As opposed to stroke
research, 2VO studies have the aim of investigation of the
long-term effects of chronic cerebral hypoperfusion. In 2VO
rats, the vessel occlusion is permanent and long-lasting,
reperfusion injury (as a result of an instant recovery of
perfusion) does not occur, the cerebral hypoperfusion is
global, and thus a distinct ischemic core and penumbra region
cannot be outlined, the damage to the nervous tissue is less
dramatic, and there are no obvious signs of motor dysfunction
or seizures.
In aging and AD, the sequence of the events of cerebral
hypoperfusion and neurodegeneration has been a subject of
debate. A chronic reduction in CBF was earlier believed to
induce the neurodegenerative processes; however, the view
was also raised that an earlier neuronal cell loss would require
a consequently lower supply of energy substrates, and there-
fore a lower perfusion rate. Following the introduction of the
concept of the neurovascular unit (the functionally integrated
network of neural and vascular cells), this controversy can be
explained: damage to any of the components of the unit
results in consequences to the functioning of the entire unit.
With the help of the 2VO model, the causal and sequential
interactions of cerebral hypoperfusion, neuronal injury and
memory deficits have been elucidated. Experimental evidence
has demonstrated the initiating role of chronic cerebral
hypoperfusion in neural damage to the hippocampus, the
cerebral cortex, the white matter (WM) areas and the visual
system. Because of the vulnerability of theWM, the retina and
the visual pathways, the 2VOmodel has recently been applied
with success in other research fields, such as ischemic WM
injury and ischemic eye diseases.
The aims of the current review are to provide a compre-
hensive survey of the experimental evidence that has
accumulated from use of the 2VO model in the rat, to relate
the results to human neurological conditions, and to consider
the particular subtleties and pitfalls of the method.2. The spatial and temporal patterns of blood
flow in experimental cerebral hypoperfusion
It has been well established that aging and dementia are
accompanied by a reduced CBF (Farkas and Luiten, 2001). The
degree of cerebral hypoperfusion observed in clinical studiesranges from ∼94% in the parietal and temporal cortices of
elderly individuals as compared with younger volunteers
(Claus et al., 1998) to ∼73% in the same regions and the
hippocampus of AD patients as compared with age-matched,
healthy controls (Farkas and Luiten, 2001). In order to tackle
the neurological and neuropathological consequences of such
a reduction in CBF, a similar condition must be created in
experimental animals. 2VO rats have long been employed to
examine the role of cerebral hypoperfusion in neurodegen-
erative processes. However, the flow pattern in 2VO rats does
not perfectly match that in aging or demented humans. The
CBF and cerebral metabolism change dynamically following
the onset of 2VO: the CBF drops sharply immediately after
occlusion induction and normalizes over months via com-
pensatory and adaptivemechanisms. There is a relatively long
period of time, during which the cerebral hypoperfusion in
2VO rats is comparable to that in humans. It is first necessary
to outline the alterations in CBF and related metabolic rates in
2VO rats.
2.1. Cerebral blood flow and metabolism
The regional CBF in selected brain structures has been
measured at a number of time points after 2VO has been
produced, ranging between 2.5 h and 6 months (Table 1). The
greatest reduction in CBF (to ∼35–45% of the control level) was
recorded in the cortical and WM areas, the CBF in the
hippocampus decreasing to a lesser extent (to ∼60% of the
control) (Ohta et al., 1997; Otori et al., 2003; Tsuchiya et al.,
1992; Ulrich et al., 1998). The CBF values had already started to
gradually recover at 1 week, but were still significantly lower
than the control values 4 weeks after 2VO induction (Otori et
al., 2003; Schmidt-Kastner et al., 2001; Tomimoto et al., 2003;
Tsuchiya et al., 1992). Between 8 weeks and 3 months, either
only a slight reduction or virtually no reduction has been
reported (Ohta et al., 1997; Otori et al., 2003). Finally, after
6 months of 2VO, the CBF was indistinguishable from the
control (Choy et al., 2006). Besides the basal flow, the
cerebrovascular reactivity was also negatively affected. The
CBF responses to challenges with acetazolamide (a vasodilator
through the inhibition of carbonic anhydrase) were impaired
from 30min to 6 weeks after 2VO initiation (Ulrich et al., 1998).
A number of the components of the brainmetabolism have
been characterized in the 2VO model, but there has been no
comprehensive study to demonstrate the parallel changes in
different variables such as the glucose metabolism, the
ATPase activity, and the ATP and lactate concentrations.
Nevertheless, the individual studies that offer data on these
variables help in the construction of an overview. The cerebral
glucose utilization was found to follow the reduction in CBF
with an initial delay and a more rapid recovery (Otori et al.,
2003; Tsuchiya et al., 1993). Furthermore, sudden depletions of
ATP and phosphocreatine were detected in the cerebral cortex
5–10 min after 2VO induction and persisted, though to a lesser
extent, for 2 weeks (Briede and Duburs, in press; Plaschke,
2005). The concentration of ATP was restored to the control
level at 8 weeks, while that of phosphocreatine still remained
significantly decreased (Plaschke, 2005). Finally, the ATPase
activity was considerably decreased, and the lactate concen-
trations in the hippocampus and cortex were increased 2.5-
Table 1 – Cerebral blood flow in chronic cerebral hypoperfusion





2 days 1 week 4 weeks 8 weeks
[14C]iodo-antipyrine Wistar, (12 weeks
old, 300–400 g)
1% halothane Parietal cortex 45.7 44.9 69.8 92.5 Otori et al. (2003)
Temporal
cortex
35.8 40.4 79 104.5
Hippocampus
CA1
78.4 67.6 66.3 100.5
Thalamus 61 57.8 78.1 108.5
Corpus
callosum










2.5 h 1 week
[14C]iodo-antipyrine Wistar
(150–270 g)
1.5–2% halothane Frontal cortex 36 65.5 Tsuchiya
et al. (1992)
















2% halothane Cortex 33.6 92.6 Choy et al. (2006)
Hippocampus 58.3 103.1
Thalamus 69.5 106.6
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data indicate that the changes in CBF can be divided into three
phases with a gradual transition with regard to the metabolic
and homeostatic state of the tissue (Fig. 1). The acute phase
immediately after the start of occlusion lasts for a maximumof 2–3 days. The CBF falls dramatically at once and remains
very low in this period, creating hypoxic–ischemic conditions,
which may compromise the electrophysiological activity of
the nervous tissue (Marosi et al., 2006). A phase of chronic
hypoperfusion follows, lasting for 8 weeks–3 months. This
Fig. 1 – The successive phases of chronic cerebral
hypoperfusion induced by permanent, bilateral occlusion of
the common carotid arteries in the rat. The phases were
determined theoretically from the degree of cerebral
perfusion, the metabolic status and the electrophysiological
activity of the nervous tissue. Abbreviations: 2VO:
permanent, bilateral common carotid artery occlusion; CBF:
cerebral blood flow.
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hypoglycemia, which corresponds with oligemia. This is the
phase which most closely resembles the condition of reduced
CBF in human aging and dementia. In the final phase of
restitution, the CBF returns to the baseline, and the cerebral
hypoperfusion, together with the suboptimal metabolism,
gradually ceases.
2.2. Compensatory mechanisms
The finding that CBF normalizes over a period of months in
the 2VO model, even though the occlusion is permanent,
indicates that compensatory or adaptive mechanisms are
turned on. Compensatory blood flowmay be provided through
artery dilation, the recruitment of nonperfused capillaries (if
there are such in the brain), and angiogenesis. Biochemical
regulation of the CBF may also play a significant part in the
adaptation.
In support of these views, experimental evidence has been
acquired on the enlargement of the arteries at the base of the
brain. The posterior vessels contributing to or emanating from
the circle ofWillis (e.g. the basilar artery, the posterior cerebral
artery, and the posterior communicating artery) exhibited
considerably increased post mortem diameter 15 weeks–
6 months after the onset of 2VO (Choy et al., 2006; Oldendorf,
1989). The initial arterial dilation is probably flow-induced,
involving the activation of nitric oxide synthase, NADPH
oxidase, and phosphatidylinositol-3 kinase (Paravicini et al.,
2006). Furthermore, vascular remodeling and arteriogenesis
take place, as indicated by the appearance of extracranial
collaterals emanating from the vertebral arteries and by the
tortuosity of the basilar and vertebral arteries (Choy et al.,
2006; Oldendorf, 1989).
At the level of the microvessels, the specific compensatory
mechanisms are still uncertain. Nitric oxide (NO) is a very
potent vasodilator, which is released at increased concentra-
tion in the brain parenchyma in response to cerebral ischemic
insults. The role of NO in ischemic brain injuries is complex
and controversial, but a recent investigation has demon-
strated the beneficial effects of NO in elevating blood flow and
promoting angiogenesis (Keynes and Garthwaite, 2004). Thereare few data on the cerebral concentration of NO in 2VO rats.
One study has revealed that the NO concentration in the
hippocampus is considerably elevated 2 weeks after 2VO
induction, but the authors did not attempt to relate this
finding to the vasoregulation (de la Torre et al., 2003). On the
other hand, an increased capillary diameter, neovasculariza-
tion, and an enhanced immunocytochemical signal for
vascular endothelial growth factor were noted in the cortex
and hippocampus after 4 weeks of 2VO. However, the findings
were not confirmed at 13weeks (deWilde et al., 2002; Ohtaki et
al., 2006). The discrepancy between these results may indicate
the occurrence of dynamic, microvascular remodeling follow-
ing the changes in CBF: growth factors may induce angiogen-
esis at lower perfusion rates (at early time points after 2VO
onset), while the capillary networkmay readjust to its original
density as the CBF normalizes.
In summary, the chronic, oligemic phase of 2VO (Fig. 1)
seems to correspond best to the chronic cerebral hypoperfu-
sion in human aging and dementia. However, in an evaluation
of its neuropathological consequences, the preceding acute
phase cannot be ignored. In order to distinguish the initial,
acute neuronal injury from the later, chronic damage, samples
must be taken from both the acute phase and the chronic
phase. Briefly, in support of chronic neurodegeneration as
opposed to the acute injury in the model, the first signs of
hippocampal damage in hematoxylin–eosin-stained sections
appeared 1 week after the initiation of 2VO and gradually
extended to the cortex during 4 weeks (Ohtaki et al., 2006).
Total unilateral destruction of the hippocampus could not be
seen after 2 weeks of 2VO, but was observed in more than half
of the animals after 13 weeks (Farkas et al., 2004b). An
assessment in the Morris water maze revealed that the spatial
memory gradually worsened as the survival times extended
from 4 weeks up to 20 weeks after the ligation of the vessels
(Liu et al., 2005). These results promote the hypothesis that the
most extensive neurodegenerative process takes place during
the chronic phase of 2VO-induced cerebral hypoperfusion (see
also the section Neuropathologic changes induced by chronic
cerebral hypoperfusion in the brain).3. The effects of chronic cerebral
hypoperfusion on the blood–brain barrier
The blood–brain barrier (BBB), the interface between blood-
borne molecules and the central nervous system, is quite
vulnerable to ischemia. For example, the BBB becomes readily
permeable to large molecules in a severely ischemic environ-
ment (Lenzsér et al., 2005; Preston and Foster, 1997). However,
there is little evidence of disruption of the BBB during healthy
aging (Mooradian, 1988; Stewart et al., 1987), and only a few
studies have indicated actual leakage of the BBB in AD
(Schlageter et al., 1987; Wisniewski et al., 1997). Similarly, to
the best of our knowledge, no evidence has been presented for
the opening of the BBB in 2VO rats. Accordingly, we propose
that the relatively mild ischemia/oligemia created by cerebral
hypoperfusion is insufficient to harm the isolating function of
the BBB, probably because disruption of the BBB is normally an
acute reaction to severe ischemia, rather than a chronically
developing pathology.
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abnormalities in the form of basement membrane thickening
and fibrous collagen deposits, which develop chronically
during aging and dementia (Farkas and Luiten, 2001). The
accumulation of collagen fibers in the microvascular base-
ment membrane may hinder specific BBB transport for
important nutrients such as glucose and essential amino
acids and could hamper the fine regulation of the regional CBF
(Farkas and Luiten, 2001). In the aging brain, a significant
correlation has been established between collagen deposits in
the microvascular wall and advancing age in the frontal and
occipital WM (Farkas et al., 2006a). Furthermore, in AD, the
proportion of capillaries displaying collagen accumulation in
the microvascular basement membrane in the cingulate
cortex was considerably higher than in age-matched controls
(Farkas et al., 2000). Whether such basement membrane
pathology is related to cerebral hypoperfusion has been tested
in the 2VO model. Electron microscopic examination revealed
microvascular basement membrane thickening and collagen
deposits comparable to those seen in the human post mortem
studies after 14 months of 2VO. The proportion of affected
capillaries in the hippocampus in 2VO rats almost doubled as
compared with controls (De Jong et al., 1999). A similar
analysis did not demonstrate significant basementmembrane
pathology 13 weeks after 2VO onset (de Wilde et al., 2002). As
very old rats (30 months) not subjected to any surgical
intervention also displayed marked capillary basement mem-
brane pathology (De Jong et al., 1990), chronic cerebral
hypoperfusion is suggested to be a causative, accelerating
condition for such age-related BBB damage.
In conclusion, the condition of the BBB in 2VO rats appears
to correspond closely to microvascular damage in the human.
While breaching of the BBB in human conditions or experi-
mental cerebral hypoperfusion cannot be clearly proven, the
capillary basement membrane pathology in the 2VO model is
very similar to the situation in human aging and dementia.
Chronic cerebral hypoperfusion is therefore regarded as a
causative factor of human BBB damage in aging and AD.4. Alterations in the electrophysiological
activity of the brain during chronic cerebral
hypoperfusion
Relatively few studies have recorded hypoperfusion-induced
changes in the electrophysiological activity of the rat brain.
The retina of 2VO rats has been flash-stimulated, and visual
evoked potentials recorded from the occipital cortex. The
latency of the positive peaks (P2) was increased, while the
amplitude (the difference between the negative and positive
peaks, N2–P2) was diminished 10 days after 2VO induction
(Aytac et al., 2006). However, these results may not reflect the
failing activity of the cerebrocortical neurons because the
retina, the optic nerves, and the optic tract are extensively
injured by the 2VO-induced hypoperfusion (see also the
section The effects of chronic cerebral hypoperfusion on the
visual system (Farkas et al., 2004a; Ohta et al., 1997; Stevens et
al., 2002)).
Another set of experiments has furnished more reliable
data on the electrophysiological activity of the hippocampusCA1 subfield after the onset of 2VO. Here, the unilateral CA3
region of the hippocampus was electrically stimulated, and
the stimulation-evoked population spikes in the contralateral
CA1 were recorded. Between 80 and 150 min after the onset of
2VO, the evoked population spike amplitudes decreased
dramatically and became undetectable. However, this func-
tional impairment proved to be reversible. When the experi-
ment was performed 3 days after the induction of 2VO, the
evoked population spikes no longer differed from those in the
sham-operated controls (Marosi et al., 2006). The explanation
for this surprising recovery is twofold: first, the silencing of
the CA1 pyramidal cells was not followed by immediate
neuronal cell death, but possibly bymetabolic adaptation; and
second, the blood flow to the hippocampus has been shown
to start recovering already on the second day after occlusion
of the vessels (Tsuchiya et al., 1992), which may contribute to
the returning functional activity of the pyramidal cells. It
would be interesting to repeat the experiment at a later time
(2–10 weeks), when hippocampal neuronal cell death is
obvious.
In another experimental approach, the electroencephalo-
gram (EEG) was recorded in rats in the acute phase of 2VO. In
half of the animals, slow waves with reduced amplitudes
appeared initially in the EEG, the rhythm of the EEG then
gradually disappeared, and finally, 300–400 s after the induc-
tion of 2VO, the EEG became isoelectric (Briede and Duburs, in
press). Again, it would be of interest to know how the EEG
changes over a longer period of time, in the chronic phase of
cerebral hypoperfusion.
The extinction of electrophysiological activity in the acute
phase of cerebral hypoperfusion appears to be consistent with
the opinion on ischemic thresholds: as the CBF gradually
decreases, the oligemia shifts to ischemia, which is defined by
the affected electrical function of the neurons. Neurons can be
rescued in the upper range of ischemia, before massive K+
efflux occurs (Obrenovitch, 1995). This may also be the
mechanism responsible for the return of evoked population
spikes reported by Marosi et al. (2006).5. Impairment of learning and memory in
chronic cerebral hypoperfusion
The hypothesis that chronic cerebral hypoperfusion contri-
butes to the progression of dementia was proposed long ago
(de la Torre, 2000; Farkas and Luiten, 2001). Traditionally, the
two most frequently used tests to measure the hippocampus-
related spatial learning capacity in chronic cerebral hypoper-
fusion in rats are the Morris water maze and the 8-arm radial
maze. In these learning paradigms, substantial evidence has
been compiled in support of learning being impaired by 2VO
(Farkas and Luiten, 2001). An increasing number of studies
have demonstrated that 2VO rats cover longer swim paths or
display longer escape latencies in the Morris water maze
(Farkas and Luiten, 2001; Farkas et al., 2004b; Liu et al., 2005;
Shang et al., 2005) and commit more errors than the sham-
operated controls in the 8-arm radial maze (Farkas and Luiten,
2001; Murakami et al., 2000; Sopala and Danysz, 2001). Thus, it
has been firmly established that experimental cerebral
hypoperfusion compromises spatial learning in rats. In
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recently made of the locomotor activity in an open field,
anxiety-related avoidance retention in an elevated T-maze,
and non-spatial memory in an object recognition test. The
total distance covered by the 2VO animals in the open field did
not differ from that for the controls, indicating that the
locomotor activity remained intact (de Bortoli et al., 2005).
However, the 2VO rats proved to be significantly impaired as
compared with the controls in an anxiety-related task, the
elevated T-maze (de Bortoli et al., 2005): as reflected by the
shorter latency of leaving the closed arm, the 2VO rats were
either less anxious to enter the open arms of the T-maze or
remembered less well that entering the open arms was
associated with anxiety. The latter explanation seems to be
the more accurate since the 2VO rats did not appear less
anxious as compared with their respective sham controls in
the elevated plus maze (deWilde et al., 2002). Finally, the non-
spatial memory in an object recognition test evaluated with a
discrimination index was also impaired in 2VO rats 60 and
90 days following occlusion of the vessels (Sarti et al., 2002a).
These data suggest that not only the visuospatial learning, but
also fear conditioning and non-spatial memory are impaired
by 2VO.
In view of the finding that the cerebral perfusion rate
changes over time in the 2VO model, it is of interest to
establish whether the learning impairment develops exclu-
sively due to the sudden drop in blood flow in the acute phase
or worsens in the chronic phase of 2VO. Hence, the learning
performance has been compared at several time points in the
2VOmodel. Tests on rats in the 8-arm radialmaze 1week after
2VO induction revealed no difference in working and refer-
ence memory scores between the 2VO and control animals,
but 16 months later the 2VO animals committed significantly
more errors (Sopala and Danysz, 2001). In the Morris water
maze, similar tendencies have been observed. The 2VO rats
performed significantly worse than the controls 4 weeks after
the onset of 2VO, and the learning impairment was consider-
ably augmented as time passed. The escape latency at
20 weeks was significantly longer than that at 4 weeks after
2VO initiation, which was reflected in the time spent in the
platform quadrant in the retention trial (Liu et al., 2005). In a
non-spatial learning paradigm, the object recognition test,
2VO rats performed as well as the controls after 30 days of
2VO, but a delayed learning impairment had developed by
60 days, which was further enhanced after 90 days (Sarti et al.,
2002a). These results convincingly support the concept that
the chronic phase of 2VO plays a major role in the gradual
deterioration of the learning ability, though damage occurring
in the acute phase of CBF reduction cannot be categorically
excluded.
A final point to consider here is whether the learning ability
can return to the normal level on the cessation of cerebral
hypoperfusion. In order to resolve this question, learning tests
with 2VO ratsmust be performed after the CBF has returned to
the baseline, i.e. more than 6months after the 2VO surgery. In
this respect, results obtained with both the Morris water maze
and the radial arm maze paradigms ∼6 months and 1 year
after 2VO induction demonstrated that the spatial learning
was impaired even at these late time points (De Jong et al.,
1999; Pappas et al., 1996). These observations suggest that the2VO-induced, permanent neuronal damage (see below) rather
than the cerebral hypoperfusion itself is correlated with the
memory failure.6. Neuropathologic changes induced by
chronic cerebral hypoperfusion in the brain
6.1. Neuronal damage
For several reasons, the favored brain region for the study
of 2VO-induced neurodegeneration is the hippocampus.
First of all, the hippocampus is the area that displays the
most characteristic neuropathological damage in AD. Sec-
ond, the hippocampus is highly implicated in spatial
learning and memory as assessed by the Morris water
maze and the 8-arm radial maze. For this reason, neuronal
injury in the hippocampus and impaired spatial learning
can be related. Third, the hippocampus (and particularly its
CA1 subfield) is one of the brain regions most sensitive to
ischemia. Finally, the distinct laminar structure of the
hippocampus and its precisely mapped synaptic connec-
tions allow exact cell-type (e.g. pyramidal cells) or layer-
specific measurements.
The most obvious signs of neurodegeneration are the loss
of neuronal cell bodies and synaptic contacts. Cerebral
hypoperfusion-induced neuronal cell death can be visualized
with conventional dyes such as hematoxylin–eosin, cresyl
violet, or toluidine blue, or with more sophisticated techni-
ques such as the TUNEL labeling of apoptotic neurons (Table
2). The conventional staining procedures revealed no con-
spicuous loss of neurons during the first week after 2VO
induction (Ohtaki et al., 2006). Later, however, increasing
neuronal damagewas noted. At 2 weeks, 6–29% of the animals
exhibited hippocampal injury in the CA1 subfield (Farkas et al.,
2006b; Ohtaki et al., 2006; Schmidt-Kastner et al., 2001). At
4weeks, this had increased to 55% (Ohtaki et al., 2006), while at
8–13 weeks, total hippocampal destruction was observed in
67% of the 2VO rats (Farkas et al., 2004b; Liu et al., 2006).
TUNEL-labeled apoptotic cell death was detected particularly
in the CA1 and CA3 regions at 2 weeks after the onset of 2VO,
with an increased rate 25 weeks later (Bennett et al., 1998).
Thus, both technical approaches demonstrated that the
neurodegeneration in the hippocampus gradually progressed
with time.
The predominant type of neuronal cell death (apoptosis
vs. necrosis) in chronic cerebral hypoperfusion has so far
remained an unresolved issue. In ischemic brain injury, both
modes of cell death occur, represented in a spatial and
temporal distribution determined by the severity of the
ischemia (Harukuni and Bhardwaj, 2006). The key determi-
nant for the mode of neuronal death is the intracellular
concentration of ATP. As a basic approach, apoptosis takes
place in the presence of ATP, while necrosis is typically
characterized by lack of the energy substrate (Ueda and
Fujita, 2004). As mentioned above, in the initial phase of 2VO,
ATP is rapidly depleted, but the ATP level returns to the
control by 8 weeks after the onset of 2VO (Briede and Duburs,
in press; Plaschke, 2005). These data suggest that necrotic cell
death most probably predominates in the acute phase of
Table 2 – Neuronal damage in the hippocampus in chronic cerebral hypoperfusion: a selection of recent data
Survival time Rat strain Anesthesia Marker Neuronal damage Reference




H&E CA1 neuronal cell death: no damage
before week 1, in 2 of 7 rats at week 1
(29%), in 6 of 11 rats at week 2–4 (55%)
Ohtaki et al.
(2006)
2, 4, and 8 weeks Wistar (250–300 g) 3% halothane H&E Neuronal damage: in 1 of 15 rats (7%) Schmidt-
Kastner et al.
(2001)




Increase in DG at 6 h
2, 4, 7, and 14 days,
16 weeks
Wistar (14 weeks) 30 mg/kg sodium
pentobarbital
AD-related factors:
APP, Sec, α7NicR, and
AchE mRNA
α7NicR increase on day 4; AchE
decrease at week 16; APP increase on
days 4 and 7; Sec increase on day 4
Tohda et al.
(2004)




Nep and IDE mRNA
Increase in all measured mRNA Hayashi et al.
(2005)
1 week, 2 and
6 months
Wistar (250–350 g) 3% halothane NeuN No focal damage, irregular labeling in



















H&E Necrotic pyramidal cells at week 2 Bennett et al.
(1998)
TUNEL Increased on weeks 2 and 27


















GAP-43: increase of mRNA, no change
in protein; MAP-2: both mRNA and
protein decrease at weeks 10 and 20;
synaptophysin: no change in mRNA,
decease in protein
Liu et al. (2005)









Thionine Neuron loss in CA1 Shang et al.
(2005)
8 weeks Wistar (320–360 g) 350 mg/kg
chloral hydrate
Toluidine blue 26% loss of CA1 pyramidal cells Liu et al. (2006)
Macroscopic
examination
Total hippocampal lesion in 4 of 6 rats
90 days Wistar (270–290 g) 1–2% halothane H&E No damage Sarti et al.
(2002a,b)
13 weeks Wistar (200–220 g) 400 mg/kg
chloral hydrate
COX-2 Reduced number of COX-2 positive





Total unilateral hippocampal lesion in
4 of 6 rats
Abbreviations: α7NicR: α7-nicotinic acetylcholine receptor, AD: Alzheimer's disease, BDNF: brain-derived neurotrophic factor, COX-2:
cyclooxygenase-2, APP: amyloid precursor protein, DG iml: dentate gyrus inner molecular layer, GAP-43: growth-associated protein-43, H&E:
hematoxylin–eosin, IDE: insulin-degrading enzyme, MAP-2: microtubule-associated protein-2, Nep: neprilysin, Sec: γ-secretase.
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in hematoxylin–eosin or cresyl violet-stained sections, while
the delayed neuronal death could be apoptotic (Bennett et al.,
1998).
The presented results lead to the question of whether the
neuronal damage observed at long survival times after 2VO
initiation is induced by the initial, ischemic phase of cerebral
hypoperfusion, or whether it is the outcome of a long-lasting
neurodegeneration caused by the chronic, oligemic phase of
2VO. In view of the limitations of the 2VO model in this
respect, this issue is difficult to resolve, but it is probable
that both the early ischemic and the later oligemic compo-nents contribute to the hippocampal neuron loss and result
in a continuous spectrum of necrotic and apoptotic cell
death.
Chronic cerebral hypoperfusion also affects the dendritic
arborizations and synaptic contacts. Microtubule-associated
protein-2 (MAP-2) is a cytoskeletal phosphoprotein associated
with dendriticmicrotubules that is thought to reflect dendritic
branching, remodeling, and plasticity (Friedrich and Aszodi,
1991) and has been regarded as a highly sensitive marker of
ischemic brain damage (Dawson and Hallenbeck, 1996). Both
the mRNA and the protein concentration of MAP-2 fell from
4 weeks to 20 weeks after the induction of 2VO, indicating a
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ishing MAP-2 signals correlated strongly with the declining
Morris water maze performance of the rats in the retention
trial (Liu et al., 2005). Synaptophysin protein, which labels
synaptic vesicles (Thiel, 1993), demonstrated a similar reduc-
tion caused by 2VO and an association with the spatial
memory (Liu et al., 2005). These data indicate that cerebral
hypoperfusion disturbs the wiring of the neuronal circuits and
the communication between the neurons, which contributes
to the learning deficiency.
6.2. Astrocytic reactions
Cerebral ischemia triggers reactive astrocytosis with detect-
able morphological signs such as hypertrophy and prolif-
eration (Panickar and Norenberg, 2005). The marker widely
used to label astrocytic proliferation is the intermediate
filament glial fibrillary acidic protein (GFAP), which accu-
mulates in reactive astrocytes. A number of studies have
been made of the presence and time course of reactive
astrocytosis in chronic cerebral hypoperfusion with the help
of GFAP immunocytochemistry. Even though astrocytic
proliferation was already detected in the cortex and visual
pathways after 1 week of 2VO, an increased GFAP signal
was not discerned in the hippocampus until 6 months later
(Farkas et al., 2004a,b, 2006b; Pappas et al., 1996; Schmidt-
Kastner et al., 2005). Astrogliosis is therefore considered to
be a late-emerging event in the hippocampus in chronic
cerebral hypoperfusion.
6.3. Microglial activation
Ischemic insults impose rapid microglial activation, which
participates in the defense of the nervous tissue, although
microglia may also transform into cytotoxic cells (Eisel et al.,
2006; Kreutzberg, 1996). The two techniques most widely
used to visualize microglia are OX-42 immunocytochemistry
and lectin histochemistry (Streit and Kreutzberg, 1987; Suzuki
et al., 1988). The antibody OX-42 is known to label CR3
complement receptors (CD11b) present on amoeboid or
activated microglia (Leong and Ling, 1992), while both resting
and activated microglia seem to possess a selective affinity
for plant-derived lectins, which provides a histological tool
with which to identify these cells (Streit and Kreutzberg,
1987).
Microglial activation has been examined at various time
points between 10 min and 6 months after the onset of 2VO.
The results obtained with OX-42 immunocytochemistry dis-
played a similar pattern: the microglial activation was already
elevated in the hippocampus at 20 min and was still obvious
13 weeks after the onset of 2VO (Abraham and Lazar, 2000;
Farkas et al., 2004b). In contrast, the lectin histochemistry
technique revealed an enhanced activation of the microglia
only in the optic tract (Schmidt-Kastner et al., 2005). Besides
the increased presence of microglia in 2VO brains, we have
observed that overt microglial activation in the hippocampal
CA1 subfield clearly coincides with pyramidal cell death in
some animals (∼15–20%) after survival for 2 weeks (Figs. 2A–F).
We assume that the animals with this accentuated histo-
pathology correspond with those with total hippocampaldestruction at 13 weeks after 2VO surgery (Figs. 2G, H) (Farkas
et al., 2004b).
6.4. Potential mechanisms for neurodegeneration
The chain of events that eventually lead to neuronal cell death
in chronic cerebral hypoperfusion begins with neuronal
energy failure due to the blood flow reduction and the
consequent hypoxia and hypoglycemia. The energy failure in
cerebral ischemia is reflected most evidently in the rapid
depletion of ATP, also found in 2VO rats (Briede and Duburs, in
press; Plaschke, 2005). In ischemic brain injury or stroke, the
loss of ATP is promptly followed by the dysfunction of energy-
dependent ion pumps, depolarization of the neurons, and the
generation of reactive oxygen species (ROS) lethal to neurons
at high concentration. The ROS in turn initiate lipid peroxida-
tion, generating lipid peroxides that are degraded to reactive
aldehyde products such as malondialdehyde (MDA) (Muralik-
rishna Adibhatla and Hatcher, 2006). In parallel with the
increase in lipid peroxidation, the activities of enzymatic
antioxidants such as Cu/Zn-superoxide dismutase (Cu/Zn-
SOD) or the concentrations of non-enzymatic antioxidants
such as glutathione (GSH) decrease (Nita et al., 2001). However,
enhanced lipid peroxidation and a decreased capacity of the
antioxidant systems have primarily been associated with
reperfusion after ischemia (Nita et al., 2001), which is very
gradual in permanent 2VO due to the flow compensation, if
reperfusion in the classical sense (the sudden return of flow)
occurs in 2VO at all. The concentration of MDA, indicative of
lipid peroxidation, was considerably increased after 10 days
of 2VO, and the activity of Cu/Zn-SOD and the concentration
of GSH were significantly decreased, as is typical of ischemic
brain injury (Aytac et al., 2006). These preliminary data
require confirmation, but it is currently considered that 2VO
creates a permanent ischemic/oligemic condition serious
enough to sustain continuous oxidative stress (probably in
both the acute and chronic phases), which could very well
be the reason for the persistent and progressive neuronal
damage.7. Chronic cerebral hypoperfusion-related
white matter injury
Cerebral WM lesions that accompany human aging and
dementia have received increasing attention as WM injury
visualized with clinical imaging techniques has been found
to coincide with cognitive and psychiatric disorders in the
elderly and AD patients (Barber et al., 1999; de Groot et al.,
2000; de Leeuw et al., 2001). Cerebral ischemia has been
hypothesized as the most probable cause of WM lesions,
but direct confirmation of the assumption requires experi-
mental models. The 2VO model has emerged as a suitable
approach, with which to unravel the potential causal
relationship between cerebrovascular insufficiency and
WM lesions.
In consequence of the anatomical arrangement of the
WM in the rat brain, the corpus callosum, the internal
capsule, and the optic tract serve as the most common and
easily delineated regions of interest for WM research. The
Fig. 2 – The neurodegenerative changes caused in the hippocampus by bilateral occlusion of the common carotid arteries in the
rat. (A–C) Cresyl violet staining to visualize the hippocampal CA1 pyramidal neurons 12 weeks after the onset of 2VO.
The photographs were taken at 40× magnification. (D–F) OX-42 immunocytochemistry to visualize microglial activation in the
hippocampus CA1 stratumoriens and stratum radiatum 12weeks after 2VO. The photographswere taken at 10×magnification.
(G and H)Macroscopic lesions of the hippocampus and cerebral cortex 13weeks after the onset of 2VO. The photograph in panel
Hwas taken at 4×magnification. Abbreviations: 2VO: permanent, bilateral common carotid artery occlusion; DG: dentate gyrus;
HPC: hippocampus; or: stratum oriens; pyr: stratum pyramidale; rad: stratum radiatum; SHAM: sham-operated control.
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routes; the severity of 2VO-induced ischemia therefore varies
from area to area (Farkas et al., 2004a, 2005). Several studies
have identified the optic tract as a predominantly vulnerable
WM region in the rat brain because of its dependence on the
direct blood supply from the internal carotid artery (Farkas et
al., 2004a; Ohta et al., 1997; Takizawa et al., 2003; Wakita et
al., 2002). The corpus callosum also exhibits typical, ische-
mia-related histopathologic changes as a consequence of
2VO, while the internal capsule seems to be better preserved
(Farkas et al., 2004a; Takizawa et al., 2003; Wakita et al.,
2002).
At various time points after the onset of 2VO, diverse
manifestations of WM injury have been described (Table 3).
The rarefaction and vacuolization of the WM in Klüver–
Barrera-stained sections are the most consistent type of
damage (Cho et al., 2006; Lee et al., 2006; Ohta et al., 1997;
Otori et al., 2003; Wakita et al., 2002). Moreover, the myelin
sheaths were disintegrated, astrocytes proliferated and
degenerated, and the microglial cells were activated (Cho etal., 2006; Farkas et al., 2004a; Lee et al., 2006). Furthermore,
apoptotic markers such as TUNEL and caspase-3 indicated the
apoptosis of oligodendrocytes and astrocytes (Lee et al., 2006;
Tomimoto et al., 2003). Finally, the accumulation of amyloid
precursor protein and chromogranin A in tortuous axons
reflected disturbed or blocked axonal transport (Wakita et al.,
2002).
The histopathological injuries observed in the 2VO model
appear to be very similar to those identified in post mortem
human WM lesions, such as WM rarefaction, demyelination,
gliosis, regressive astrocytic changes, and the apoptotic cell
death of oligodendrocytes and astrocytes (Kobayashi et al.,
2002; Scheltens et al., 1995; Thomas et al., 2002; Tomimoto et
al., 1997). Thus, the experimental evidence has confirmed the
ischemic origin of WM lesions. Accordingly, 2VO in rats is
regarded as an appropriate model for the reconstruction of
histopathologic changes in human ischemic WM lesions.
Recent studies have demonstrated that the 2VO model can
be used for the development and testing of neuroprotective
strategies with therapeutic prospects forWM injury (Cho et al.,
Table 3 – Histopathology in the cerebral white matter in chronic cerebral hypoperfusion: a selection of recent data
Survival time Staining WM site Histopathology Reference
1 h, 1, 3, 7, 14,
and 30 days
Klüver–Barrera Optic tract, internal capsule,
corpus callosum, fiber bundle
of the caudate putamen
WM rarefaction: from day 3 on Wakita et al.
(2002)Bielschowsky silver Swollen fibers
APP: fast axonal transport Increased signal, peak between days 7–14
CgA: anterograde axonal flow Gradually increasing signal from day 1 to
day 30EP: degradation of myelin
1 h, 1, 3, 7, 14,
30, and 90 days
Apoptosis markers: Corpus callosum Protein increase between day 1 and 30 Tomimoto




Increased signal on days 7–14Bax
Immunolabeled after 2VOTUNEL
TNFα: proinflammatory cytokine
2 days, 1, 4, and
8 weeks
Klüver–Barrera Corpus callosum, internal
capsule
WM rarefaction, vacuolization Otori et al.
(2003)
3, 7, 14, and
30 days








TNFα: proinflammatory cytokine Increase
2 weeks Klüver–Barrera Optic tract, internal capsule,
corpus callosum
WM lesions Wakita et al.
(2003)Bielschowsky silver Increase
APP: fast axonal transport
2 weeks Klüver–Barrera Optic tract, internal capsule,
corpus callosum
Vacuolization Cho et al.
(2006)Bielschowsky silver Axonal damage
MBP: myelin integrity Decrease




8 weeks Hematoxylin–eosin Optic tract, corpus callosum,
cingulum bundle,
caudoputamen
Increase in % of vacuoles Takizawa
et al. (2003)
13 weeks GFAP: astrogliosis Optic tract, internal capsule,
corpus callosum
Increase Farkas et al.
(2004a, 2005)OX-42: microglial activation Increase
MBP: myelin integrity Increase
Electron microscopy
Optic tract
myelin sheath damage, increased
oligodendrocyte density
4 months Klüver–Barrera Optic tract WM rarefaction, vacuolization, gliosis Ohta et al.
(1997)
Abbreviations: APP: amyloid precursor protein, CgA: chromogranin A, EP: encephalitogenic peptide GFAP: glial fibrillary acidic protein, MBP:
myelin basic protein, MMP-2: matrix metalloproteinase-2.
WM: white matter.
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2003).8. The effects of chronic cerebral
hypoperfusion on the visual system
The 2VO model in rats has also been applied for ischemic eye
research. In investigations of the ischemic component of
diabetic retinopathy, chronic glaucoma, or ocular ischemic
syndrome, a number of 2VO-induced functional and mor-
phological pathologies of the optic system have been
identified (Lavinsky et al., 2006; Yamamoto et al., 2006).
Approximately 50% of 2VO animals lose their pupillary reflex
(Davidson et al., 2000; Lavinsky et al., 2006; Stevens et al.,2002), which makes the retina exceedingly vulnerable to light
exposure and is probably involved in the abnormal circadian
rhythm of the animals (Ohta et al., 1997). Furthermore, the
electroretinograms have demonstrated that the b-wave
amplitude, representing on-bipolar and Müller cell activity
in response to light, is dramatically decreased 7 days after the
onset of 2VO (Barnett and Osborne, 1995). In contrast, the a-
wave amplitude reflecting the photoreceptor function is
significantly increased, indicating that the photoreceptor
utility is maintained for up to 7 days (Barnett and Osborne,
1995).
These functional changes are accompanied by structural
damage. Macroscopic examination and Gallyas staining of the
optic nerves revealed considerable atrophy associated with
loss of the pupillary reflex (Ohta et al., 1997; Stevens et al.,
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ofmyelin disintegration, excessive astrogliosis, andmicroglial
activation labeled with immunocytochemistry (Farkas et al.,
2004a). The total retinal thickness of 2VO rats that lost their
pupillary reflex fell from ∼120 μm to ∼87 μm, while 2VO rats
with a preserved pupillary reflex displayed no reduction in
total retinal thickness (Lavinsky et al., 2006). Particularly the
synaptic zones, the inner and outer plexiform layers appeared
to be markedly affected, as shown in representative photo-
graphs taken after 2 weeks of 2VO (Fig. 3). The loss of
ganglionic cells that followed the integrity of the pupillary
reflex could be observed from 1 week on and was most
dramatic from 90 days on (Stevens et al., 2002; Yamamoto et
al., 2006). Receptor cell loss was delayed as compared with the
ganglionic cell pathology and was detected from 2 months onFig. 3 – The differential degeneration of the retina caused by
bilateral occlusion of the common carotid arteries in the rat.
Twelve weeks after the vessel ligations, the
hematoxylin–eosin-stained retina sections of some rats
appeared spared (B), while those of others were severely
injured (C). There is a noteworthy narrowing of the synaptic
zones (IPL and OPL) indicated by arrowheads. The
photographswere taken at 40×magnification. Abbreviations:
2VO: permanent, bilateral common carotid artery
occlusion; IPL: inner plexiform layer; OPL: outer plexiform
layer; SHAM: sham-operated control.(Yamamoto et al., 2006). Thus, about half of 2VO rats display
an impaired visual ability.
These observations appear to be rather disturbing for
researchers investigating cognitive dysfunctions caused by
2VObecause spatialmemory is frequently assessed in learning
tests that are based on visual cues. Themost popular memory
tests in general use for 2VO rats are theMorris watermaze and
the 8-arm radial maze (Farkas and Luiten, 2001). In order to
distinguish the contribution of visual impairment from the
hippocampal neuronal damage to the spatial learning dys-
function, various approaches have been employed.
When 2VO rats were divided into groups based on the
presence or absence of the pupillary reflex, both groups
committed more errors in the 8-arm radial maze as
compared with the sham-operated controls, but the rats
with an impaired pupillary reflex performed noticeably worse
than the group with an intact reflex (Davidson et al., 2000). In
another study, the learning capacities of rats with bilateral
internal carotid artery occlusion or with 2VO were compared.
In the Morris maze, the internal carotid artery-occluded
animals did not perform worse than the controls, whereas
the 2VO animals did. In the 8-arm radial maze, the results
resembled those obtained with the groups based on pupillary
reflex integrity: both the internal carotid artery-occluded and
the 2VO groups committed more errors than the controls,
and the 2VO group gave the worst performance (Ohta et al.,
1997).
These experiments suggest that cerebral hypoperfusion
itself compromises the learning process, but damage to the
visual system aggravates the test results that depend on
visual cues. It is highly likely that hypoperfusion severe
enough to damage the retina has a more dramatic impact on
the hippocampus and the related memory processes.
Auditory and tactile stimuli also guide rats in spatial
learning; this is especially true for albino rats with limited
vision. In support of this view, rats blind in one eye are able
to navigate as well as binocular animals in the Morris water
maze (Panakhova et al., 1986). The concerns as to the exact
role of impaired vision in spatial learning in the 2VO model
remain unresolved because of the lack of unequivocal
evidence. However, it is certain that 2VO induces learning
deficits because non-visual learning characterized in the
elevated T-maze and in an object recognition test is clearly
affected in the model (de Bortoli et al., 2005; Sarti et al.,
2002a).9. Systemic changes following experimental
cerebral hypoperfusion
9.1. Body weight
Like larger surgical interventions in general, 2VO is followed
by a decrease in body weight. On postoperative days 1 and
2, a loss in body weight can be observed in both the sham-
operated and 2VO groups. Since certain muscles in the
ventral cervical region (e.g. the sternohyoid and the
sternomastoid muscles) are slightly damaged during the
preparation of the carotid arteries, discomfort during move-
ment of the head, mastication, and swallowing may
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animals (which undergo all surgical procedures but the
actual vessel ligation) start to regain weight rapidly, while
the 2VO animals lag somewhat behind, even up to 10 weeks
after the onset of 2VO (Farkas et al., 2002a). The slower gain
in body weight following 2VO cannot be attributed to the
surgical method since the control animals are exposed to
the same procedures. A potential increase in sympathetic
tone or hormonal changes due to the ligation may be
considered responsible for the delayed weight gain. On the
other hand, the blood flow to the hypothalamus, a major
center of autonomic control, is also markedly reduced in the
2VO model (Otori et al., 2003; Tsuchiya et al., 1992), which
may compromise the hypothalamic function. Unfortunately,
experimental data on the relationship between chronic
cerebral hypoperfusion, hypothalamic injury, and autonomic
regulation are scarce.
9.2. Blood pressure
As a consequence of 2VO, the blood flow decreases dramati-
cally in the carotid sinus, where baroreceptors continuously
monitor the blood pressure. The sudden drop in blood
pressure triggers a cardiovascular baroreflex, increases the
sympathetic tone, and initiates a hypertensive response. Early
reports described the hypertensive response after 2VO sur-
gery, indicated by increases in blood pressure and heart rate
(Krieger, 1963; Wang et al., 1970). With the help of a femoral
artery canule, the mean arterial pressure in awake laboratory
ratswas demonstrated to increase by approximately 65mmHg
relative to the baseline in the acute phase of 2VO (15–60 s)
(Parra et al., 2005). Our experiments followed the long-term
changes in systolic blood pressure measured with the tail cuff
method in unrestrained, awake rats from 24 h up to 9 weeks
after the onset of permanent 2VO. Even as long as 9 weeks
after vessel occlusion, the systolic blood pressure displayed a
sustained, significant increase of 10–12 mmHg over the
baseline (Fig. 4), even though the aortic baroreflex loop was
intact. Similar results were obtained under halothane
anesthesia for the mean arterial pressure (Otori et al., 2003).Fig. 4 – Change in systolic blood pressure after bilateral occlusio
pressure was measured repeatedly on freely moving, awake rats
bilateral common carotid artery occlusion; SHAM: sham-operateThese results indicate a persistent elevation of the sympa-
thetic tone in the permanent 2VO model.
9.3. Plasma hormone concentration
Experimental evidence on plasma hormone concentrations in
animalswith2VO is scarce, although the increased sympathetic
tone implies the involvement of hormonal regulation. An
increased release of vasopressin as a direct response to 2VO
has been repeatedly demonstrated (Clark and Silva, 1967;
Dreifuss et al., 1976), but the chronic hormonal changes have
not been investigated. Likewise, the plasma concentrations of
catecholamines and angiotensin, assessed in dogs, proved to
be elevated during the acute phase of 2VO (Brassard and
Yamaguchi, 1989; Hodge et al., 1966), but less is known about
the chronic hormonal fluctuations in permanent 2VO. Finally,
even though acute changes in the plasma concentration of
corticosterone have not been recorded, our experiments
demonstrated that 2VO persisting for 3 months caused a
significant increase in the circulating corticosterone level in a
stressful situation (Farkas et al., 2002b). Besides their partici-
pation in the sympathetic response, these hormonal changes
may be of metabolic significance and contribute to the slower
gain in body weight in the 2VO animals.
9.4. Leukocyte stimulation
In a search for peripheral inflammatory markers, the
formation of leukocyte–platelet aggregates and the activation
of neutrophil granulocytes have been identified in blood
drawn from the jugular vein after cerebral ischemia–reperfu-
sion injury (Ritter et al., 2005). Similarly, the enhanced
aggregation of leukocytes and neutrophil activation were
observed in blood from the femoral and jugular veins of rats
5 h after the onset of 2VO, as compared with the sham-
operated controls (Sancesario et al., 1997). Even though these
changes have been primarily associated with reperfusion
injury, the results from the 2VO experiment infer that
cerebral hypoperfusion itself may generate a systemic
inflammatory response.n of the common carotid arteries in the rat. Systolic blood
with the tail cuff method. Abbreviations: 2VO: permanent,
d control.
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This survey has provided illustrative examples of systemic
changes in response to 2VO. The conventional approach to
the causal interaction between peripheral changes and
cerebrovascular events examines the effects of peripheral
risk factors on cerebrovascular pathology. However, as the
experimental evidence presented here compellingly demon-
strates, cerebrovascular injury can evoke a complex set of
systemic reactions. The importance of these observations
may be appreciated when routinely applicable diagnostic
tools are designed for the prediction and follow-up of chronic
cerebrovascular insufficiencies.10. Methodological considerations
10.1. Species and strains
It is widely known that 2VO induces neuronal damage with
varying degrees of severity in different mammal species. Two
species frequently employed for carotid occlusion studies are
the rat and the gerbil. These two models create distinct
ischemic conditions in the brain. Because of the lack of
communicating arteries between the carotid and vertebral
systems, carotid occlusion in the gerbil leads to severe
forebrain ischemia. In contrast, the complete circle of Willis
in the rat affords compensatory flow from the vertebral
arteries to the regions that would normally be supplied by
the ligated carotid arteries; the 2VO in the rat therefore causes
cerebral hypoperfusion rather than stroke.
Besides the clear-cut differences between species, a
number of studies have also drawn attention to variations
between strains. Thus mouse strains with an enhanced
susceptibility to global cerebral ischemia (e.g. C57black/6)
displayed less well developed posterior anastomoses or an
incomplete posterior communication in the circle of Willis
(Beckmann, 2000; Fujii et al., 1997). Similar observations on
anatomical variations of the circle of Willis were published
about gerbils obtained from different vendors (Breuer and
Mayevsky, 1992; Laidley et al., 2005). Among rat strains, the
CA1 hippocampal subfield of Fischer 344 rats appeared to be
more vulnerable to 2VO combined with hypotension than
those of Sprague–Dawley andWistar rats (Iwasaki et al., 1995).
Even a particular rat strain from different suppliersmay be the
source of differences in ischemic tolerance. The amplitude of
population spikes in the hippocampal CA1 region evoked by
electrical stimulation of the contralateral CA3 subfield
decreased more dramatically after the onset of 2VO in Wistar
rats supplied by Harlan as compared withWistar rats from the
Charles-River Laboratories (Marosi et al., 2006).
All these data suggest that, depending on the cerebrovas-
cular condition to be reproduced experimentally, the most
suitable strain must be chosen for the purpose. For example,
Wistar rats appear to be ideal for the study of chronic cerebral
hypoperfusion by imposing 2VO because the blood flow
through the collaterals and the ischemic tolerance of the
nervous tissue are relatively good. Furthermore, data analysis
and comparison with results published by others must take
any strain differences into account.10.2. Anesthetics
The method of anesthesia applied must be considered
because various anesthetics may exert different effects on
the autonomic responses and cerebral metabolic rate in the
2VO model. In this respect, the effects of different anesthetics
on physiological measures such as the mean arterial pressure
and heart rate have been evaluated in 2VO rats. Under sodium
thiopental, sodium pentobarbital, or alpha-chloralose
anesthesia, 2VO elicited a systemic arterial pressor response
comparable to that in conscious animals, while ketamine
hydrochloride plus acepromazine was not as reliable. The
stability of the baseline values for heart rate and arterial
pressure indicated that sodium thiopental and sodium
pentobarbital were the most suitable anesthetics for the
measurement of systemic responses to 2VO (Lash et al., 1992).
Since certain anesthetics (e.g. halothane, ketamine, or
isoflurane) are thought to furnish neuroprotection in ischemia
by reducing the cerebral metabolic rate, some research groups
have set out to characterize and compare the neuroprotective
capacities of these agents. When 2VO was combined with
hypotension, which also resulted in isoelectric EEG, measure-
ment of the histological damage in the hippocampus pointed
to isoflurane as the most neuroprotective anesthetic (Miura et
al., 1998; Nellgard et al., 2000). However, when the EEG activity
was maintained in the same model, no significant difference
in neuroprotection could be established between isoflurane,
ketamine, and fentanyl (Miura et al., 1998). 2VO has been
demonstrated to lead to isoelectric EEG 300–400 s after
occlusion of the vessels in a small proportion of rats (Briede
and Duburs, in press), and isoflurane anesthesia may there-
fore blunt the 2VO-induced neurodegenerative processes.
Furthermore, isoflurane has been shown to attenuate ische-
mia-induced glutamate release in the hippocampus (Patel et
al., 1995). Whether the accentuated neuroprotective capacity
of isoflurane as compared with other anesthetics is an
advantage or a disadvantage in the 2VO model is a difficult
question to resolve, but the choice of anesthesia remains a
factor that may account for variations between studies
involving the use of different agents.
10.3. Other technical approaches
The widespread use of 2VO indicates that this has proved to
be a suitable method with which to reconstruct the cerebral
hypoperfusion-induced components of human dementia.
Nonetheless, because of the flow characteristics in 2VO
rats, some modification of the model may be justified in
the future.
A few attempts have recently been made to refine the 2VO
model in order to avoid the acute phase directly after the
occlusion. These studies focus on exploring technical solu-
tions so as to be able to examine the neural consequences of
gradually developing chronic cerebral hypoperfusion, or of
atherosclerosis in the carotid bifurcation, as occurs in human
aging and dementia. To this end, silicone collar cuffs were
positioned around the common carotid arteries with the aim
of reproducing the inflammatory response caused by athero-
sclerosis. This resourceful manipulation, however, did not
cause long-term memory impairment (de Bortoli et al., 2005).
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carotid arteries separately, at an interval of 1 week, which
would allow hypoperfusion in the brain to develop more
gradually (Sarti et al., 2002b). A late-emerging, progressive
learning dysfunction has been induced with this approach in
an object recognition test and the Y-maze (Sarti et al., 2002a).
However, the method also involves a sudden drop in blood
supply, even though this is unilateral, and probably shorter
than in 2VO. An additional complicating factor is that the rats
have to undergo anesthesia twice in a week, which causes
further distress to the animals.
A further possibility is balloon angioplasty. This interven-
tion involves the insertion of an inflatable balloon to the
carotid bifurcation via the external carotid artery. Once in
position, the balloon is inflated and withdrawn some milli-
meters a few times to trigger endothelial damage. The balloon
is then removed, and the external carotid artery is closed. This
method causes intimal hyperplasia and arterial stenosis
(Clowes et al., 1983) and is a commonly usedmodel for clinical
arterial reconstruction surgery (Zubilewicz et al., 2001). The
cerebral hemodynamic, behavioral, and neuropathological
consequences of balloon angioplasty in the rat are not
known. Since the narrowing of the carotid arteries develops
gradually in this model, a possible change in CBF and the
development of neurodegenerative processes may be worth
investigating.
10.4. Standardization
As shown in Figs. 2 and 3, the degree of neuronal and retinal
damage varies greatly, even within the same experiment,
where the variables (including the strain, the anesthetic, and
the investigator performing the surgical interventions) are
kept at a minimum. The source of this heterogeneity is
probably the cerebrovascular architecture or the ischemic
tolerance of the nervous tissue of the individual animals, as is
the case with humans. As an additional factor, the age of the
animals at the time of 2VO surgerymay also be responsible for
the heterogeneity. The proportion of rats with severe brain
damage after the onset of 2VO appears to be higher when the
animals are young at the time of the surgery (body weight
<250 g, personal observation).
Standardization of the experiments is a reasonable require-
ment as concerns reproducibility and interpretation. Since the
2VO model has been generally used for the investigation of
chronic cerebral hypoperfusion, such standardization should
be aimed at the selection of rats that do not suffer severe
ischemic brain damage.
Laboratories that use the 2VO model should agree on the
selection criteria, though a number of variables complicate the
development of such standards. For example, the heteroge-
neity of the survival times and the particular techniques used
to collect data (e.g. flowmetry, electrophysiology, behavioral
physiology, and histology) require different definitions for
their standards. The observation and neurological evaluation
of the motor dysfunction after 2VO surgery could be a rough
approach, but 2VO animals do not display clear motor deficits
like those observed in stroke models (Sarti et al., 2002a). As a
consensus, brain slices containing the dorsal hippocampus
could be stained with traditional dyes such as cresyl violet orhematoxylin–eosin, and the damage to the CA1 pyramidal
cells (one of the most vulnerable areas that is easy to define)
could be graded for given survival times. Such a grading
system could serve as a selection criterion via which to
separate animals with severe ischemic brain damage from
those with mild, cerebral hypoperfusion-related injury.11. Summary and conclusions
The cerebral hemodynamic, metabolic, functional, and
neuropathological data necessitated a survey of the achieve-
ments with the 2VO model. The nature and gravity of the
insult inflicted by 2VO, and the severity of the consequent
neuronal damage demand a review because they have not
been comprehensively and conclusively determined. Most
investigators agree that the level of cerebral hypoperfusion in
the model is moderate, and the resulting neuronal injury is
relatively mild. However, the terms ischemia and oligemia
are used inconsistently in the literature to describe the
condition produced. The terminology for ischemic thresholds
in ischemic penumbra research may serve as a guideline for
the proper identification of the 2VO-induced conditions. In
this terminology, oligemia means a range of cerebral
hypoperfusion where the electrical function of the nervous
tissue is not yet affected. Ischemia denotes a condition
where the flow values are low enough to cause electrical
failure and a massive K+ efflux into the extracellular space
(Obrenovitch, 1995).
In the 2VO model, ischemia is followed by oligemia
corresponding with the acute and chronic phases as shown
in Fig. 1, but spatial variations are also present, depending on
the angioarchitecture and the vulnerability of specific brain
regions. For example, the optic tract may undergo ischemia,
while at the same time the hippocampus could be in the
oligemic phase, as reflected by the CBF values and the
histologic damage (Tables 1–3). The terms ischemia and
oligemia in the 2VO model should therefore be used with
care and selectively, with consideration to the time after
occlusion of the vessels, and the brain region investigated.
As regards the issue of acute and chronic neurodegenera-
tion in the 2VO model, some researchers have expressed
concern that the neuronal damage could primarily occur in
the acute phase as opposed to the chronic phase of 2VO. The
current survey has demonstrated that the neuropathology,
together with the learning dysfunction, is progressive and is
not caused exclusively in the acute phase.
Impairment of the visual system after 2VO induction led to
further doubts as to the outcome and interpretation of spatial
orientation tasks based on visual cues. As detailed above, no
explicit solution has been found to distinguish the share of
visual impairment in the poor performance of 2VO rats in the
Morris maze and the 8-arm radial maze. However, other non-
visual learning paradigms (e.g. the elevated T-maze and the
object recognition test) recently introduced in 2VO studies
clearly demonstrate that the memory processes are progres-
sively disturbed in the model.
Most published 2VO studies have been descriptive, and
only a few groups of researchers have set out to unravel the
exact intracellular and biochemical mechanisms that lead to
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experimental data may be that unsuccessful attempts have
not been published, or the demand for such information has
not been high, but the role of oxidative stress in 2VO-
induced neurodegeneration could be an attractive target of
investigation that could be extrapolated to human cerebral
hypoperfusion.
Overall, the 2VO rat model has prompted an under-
standing of the causative role played by cerebral hypoperfu-
sion in neurodegenerative diseases. Future 2VO studies could
well unravel the hypoperfusion-related biochemical mechan-
isms involved in neuronal damage. As a final point, the 2VO
model has now been extensively characterized, and it seems
highly suitable for the testing of potentially neuroprotective
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